Back to Search Start Over

Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors' Organisation centers for patients with unclassified bleeding disorders.

Authors :
Thomas W
Downes K
Evans G
Gidley G
Lowe G
MacDonald S
Obaji S
O'Donnell JS
Palmer B
Pinto F
Desborough M
Source :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Nov; Vol. 19 (11), pp. 2738-2743. Date of Electronic Publication: 2021 Aug 25.
Publication Year :
2021

Abstract

Background: Bleeding of unknown cause (BUC) and unclassified bleeding disorders (UBD) are increasingly recognized. There is no guidance on diagnosis and management.<br />Objectives: To examine UK haemophilia centre registration patterns and current practice for UBD patients.<br />Methods: In a two-step process, the UK National Haemophilia Database (NHD) was reviewed for registration patterns of UBD patients and a survey of UK haemophilia centers was conducted (January/February 2021) to capture current practice for diagnosis and management of patients with UBD.<br />Results/discussion: Overall, registrations with the NHD for UBD patients has sharply risen from 2012 to 2020 and in 2019 accounted for 2.65% of registered patients. For the survey, the response rate was 52/67 (78%). Practice was widely variable; 35/52 (67%) centers register UBD; among these 35 centers, terminology included UBD (28 centers), undiagnosed bleeding disorder (four centers), and BUC (three centers); 34/52 (65%) centers use a formal bleeding assessment tool. For management of dental extraction and high bleeding risk surgery in a fictional UBD patient we found that tranexamic acid was widely used; however, beyond this a variety of hemostatic products were advised including blood products, recombinant factor VIIa/prothrombin complex concentrate, and desmopressin. There was general consensus (≈90%) on avoiding regional anesthesia in pregnancy, but no agreement on the need for fetal precautions to avoid bleeding at delivery (50% would advise these). There was a disparity of opinion on chemical thromboprophylaxis, and management of patients without prior hemostatic challenges and offspring of these patients.<br />Conclusion: This study provides a snapshot of current practice and real-world data in this area. Future studies need to address the gaps in evidence.<br /> (© 2021 International Society on Thrombosis and Haemostasis.)

Details

Language :
English
ISSN :
1538-7836
Volume :
19
Issue :
11
Database :
MEDLINE
Journal :
Journal of thrombosis and haemostasis : JTH
Publication Type :
Academic Journal
Accession number :
34382329
Full Text :
https://doi.org/10.1111/jth.15492